News, Policy & Publications

Drug Safety MHRA Drug Safety Update

MHRA Drug Safety Update April 2012

Below is the April newsletter from the Medicines and Healthcare products Regulatory Agency and its independent advisor the Commission on Human Medicines. To download, please click here.

Drug safety advice

• Proton pump inhibitors in long-term use: reports of hypomagnesaemia

• Proton pump inhibitors in long-term use: recent epidemiological evidence of increased risk of bone fracture

• Tolvaptan (Samsca): over-rapid increase in serum sodium and risk of serious neurological events

Other Information From The MHRA

• Learning about reducing medicines risk

To view the previous MHRA drug safety updates pleas click on the links below.

• March

• February

• Jaunary